Shawn Tomasello
Chairman at GAMIDA CELL LTD.
Net worth: 32 350 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sol Barer | M | 76 | 37 years | |
| Theresa Janke | F | 49 | 11 years | |
| Michael Amoroso | M | 46 | 4 years | |
| David Kirn | M | 62 | 11 years | |
| James N. Campbell | M | 76 | 11 years | |
| Julian Adams | M | 69 | 8 years | |
| Steven Nichtberger | M | 62 | 7 years | |
| Malcolm K. Brenner | M | 72 | 11 years | |
| Niranjan Y. Sardesai | M | 56 |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 7 years |
| Elizabeth Barrett | F | 62 | 5 years | |
| Diana Brainard | M | 53 | 5 years | |
| Paul Hughes | M | - | 5 years | |
| Anup Marda | M | 46 | 5 years | |
| Fariborz Kamal | M | 61 | 6 years | |
| Dong Kim | M | 47 | 3 years | |
| Scott Bizily | M | 52 | 3 years | |
| Jeffrey Kindler | M | 68 | 11 years | |
| Noriyuki Kasahara | M | 62 | 2 years | |
| Vikas Sinha | M | 60 | 6 years | |
| Juan F. Vera | M | 44 | 11 years | |
| Abbey Jenkins | F | - | 2 years | |
| Catherine Bollard | M | 56 | 5 years | |
| Ann M. Leen | M | 47 | 11 years | |
| Stephen Wills | M | 67 | 5 years | |
| Gill Marshall | M | - | 4 years | |
| Greg Gin | M | - | 4 years | |
| Peter Olagunju | M | - | 3 years | |
| Samik Basu | M | - | 5 years | |
| Philip Krause | M | - | 2 years | |
| Joann Peters | F | - |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 5 years |
| Julian Pei | M | - | - | |
| Jason Smith | M | 52 | 4 years | |
| Nancy Miller-Rich | F | 65 | 4 years | |
| Ivan Borrello | M | 60 | 2 years | |
| Michael Gerard | M | 44 | 3 years | |
| Richard Henriques | M | 68 | 5 years | |
| William Bertrand | M | 59 | 1 years | |
| Philip Facchina | M | 62 | 3 years | |
| Kenneth Moch | M | 69 | 8 years | |
| Susannah Gray | F | 63 | 4 years | |
| Morana Jovan-Embiricos | M | 57 | 5 years | |
| David Hallal | M | 57 | 6 years | |
| Jeffrey Bornstein | M | 57 | 4 years | |
| Mary Coelho | F | 62 | 1 years | |
| Charles Theuer | M | 60 | 8 years | |
| Wulff-Erik von Borcke | M | - | 9 years | |
| Jacob Chacko | M | 45 | 5 years | |
| Mark Simon | M | 62 | 6 years | |
| Edward Miller | M | 59 | 5 years | |
| John Milligan | M | 63 | 4 years | |
| Derek Adams | M | 50 | 1 years | |
| Scott Brun | M | 56 | 3 years | |
| Robert Kim | M | 63 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sean Whelan | M | 53 | 6 years | |
| Ian Clark | M | 62 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 14 years |
| Jacqualyn Fouse | M | 62 | 7 years | |
| Ansbert Gadicke | M | 66 | 8 years | |
| Robert Duggan | M | 79 | 7 years | |
| Phil Hagerman | M | 71 | 45 years | |
| John Wilson | M | 64 | 9 years | |
| Jonathan Biller | M | 61 | 8 years | |
| Arie Belldegrun | M | 74 | 8 years | |
| Ramses Erdtmann | M | 60 | 6 years | |
| Atul Kavthekar | M | 56 | 2 years | |
| Clarissa Desjardins | M | 57 | 8 years | |
| Roy C. Hardiman | M | 64 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 25 years |
| Garry Menzel | M | 59 | 7 years | |
| Charlie Harrison | M | - | 9 years | |
| Gary Rice | M | 66 | 8 years | |
| Gil Hakim | M | 54 | 8 years | |
| Scott Smith | M | 61 | 10 years | |
| Benjamin Wolin | M | 49 | 5 years | |
| David Schaffer | M | 53 | 9 years | |
| Diane Parks | F | 72 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Robert A. Swanson | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Christopher Chai | M | 58 | 7 years | |
| Heather DiVecchia | F | - | 6 years | |
| Timothy Moore | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 3 years |
| Manmeet Singh Soni | M | 46 | 3 years | |
| Joao Siffert | M | 60 | 2 years | |
| Stephen Webster | M | 63 | 3 years | |
| Thomas Daniel | M | 69 | 10 years | |
| Patrick Baeuerle | M | 66 | 6 years | |
| David Bonita | M | 48 | 6 years | |
| Peter Kellogg | M | 67 | 5 years | |
| G. Kirk Raab | M | 88 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| David Tanen | M | 52 | - | |
| Perry Karsen | M | 69 | 9 years | |
| Alan Colowick | M | 61 | 10 years | |
| Louis Lavigne | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Peter Pfreundschuh | M | 55 | 2 years | |
| George Manor | M | - | 2 years | |
| David C. Dreyer | M | 67 | 6 years | |
| Thomas E. Michaels | M | - | 6 years | |
| Michael E. Flowers | M | - | 2 years | |
| Regina Benjamin | M | 67 | - | |
| Carrie Cox | F | 66 | 10 years | |
| Richard W. Barker | M | 75 | 7 years | |
| Michael Friedman | M | 80 | 8 years | |
| Donal O'Dwyer | M | 71 | 18 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 86.00% |
| Israel | 7 | 7.00% |
| Australia | 5 | 5.00% |
| Canada | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shawn Tomasello
- Personal Network
